ESSEX INVESTMENT MANAGEMENT CO LLC – CRISPR Therapeutics AG Transaction History
ESSEX INVESTMENT MANAGEMENT CO LLC portfolio value:
$1.18M
portfolio value
ESSEX INVESTMENT MANAGEMENT CO LLC quarter portfolio value change:
+7.54%
quarter
CRISPR Therapeutics AG 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +45.29% | 5.66K shares | 428K | $65.35 | 18.18K |
| Q2 2022 | share | Decrease | -59.38% | -18.29K shares | -1.17M | $60.77 | 12.51K |
| Q1 2022 | share | Decrease | -6.14% | -2.01K shares | -554K | $62.77 | 30.81K |
| Q4 2021 | share | Decrease | -3.37% | -1.14K shares | -1.31M | $78.85 | 32.82K |
| Q3 2021 | share | Increase | +0.41% | 138 shares | -1.67M | $111.93 | 33.97K |
| Q2 2021 | share | Decrease | -4.79% | -1.70K shares | 1.14M | $161.89 | 33.83K |
| Q1 2021 | share | Increase | 0.00% | 35.54K shares | 4.33M | $121.85 | 35.54K |
| Q4 2020 | share | Decrease | -100.00% | -41.96K shares | -3.51M | $153.11 | 0 |
| Q3 2020 | share | Decrease | -0.14% | -60 shares | 422K | $83.64 | 41.96K |
| Q2 2020 | share | Decrease | -18.19% | -9.34K shares | 909K | $73.49 | 42.02K |
| Q1 2020 | share | Decrease | -38.44% | -32.07K shares | -2.90M | $42.41 | 51.37K |
| Q4 2019 | share | Increase | +5.87% | 4.62K shares | 1.85M | $60.91 | 83.44K |
| Q3 2019 | share | Decrease | -7.92% | -6.78K shares | -801K | $40.99 | 78.81K |
| Q2 2019 | share | Increase | 0.00% | 85.59K shares | 4.03M | $47.1 | 85.59K |
| Q3 2018 | share | Decrease | -100.00% | -40.93K shares | -2.40M | $44.35 | 0 |
| Q2 2018 | share | Increase | +87.88% | 19.14K shares | 1.41M | $58.76 | 40.93K |
| Q1 2018 | share | Decrease | -57.34% | -29.29K shares | -203K | $45.71 | 21.79K |
| Q4 2017 | share | Increase | 0.00% | 51.08K shares | 1.19M | $23.48 | 51.08K |